Hainan Star

Star Pharmaceutical Limited, operating through its key subsidiary Hainan Star Pharmaceutical Co., Ltd., is a China-based pharmaceutical company focused on the research, development, and manufacturing of various medicinal products. The company specializes in anti-infectives, cardiovascular drugs, and respiratory treatments, with a strong emphasis on freeze-dried powder injections and other Western medicines. Star Pharmaceutical operates a large-scale, GMP-certified manufacturing base in Haikou, Hainan Province, which serves as its primary production hub. The company markets its products across mainland China through an extensive network of distributors and sales representatives. Formerly listed on the Singapore Exchange, Star Pharmaceutical was privatized in 2021 and continues to focus on expanding its presence in the Chinese healthcare market through both Western medicine and modernized Traditional Chinese Medicine.